Gerresheimer AG (XSWX:GXI) Common Stock: CHF32 Mil (As of Aug. 2025)


XSWX:GXI Gerresheimer AG XSWX:GXI
73 GF Score
Price CHF25.02
GF Value CHF87.96
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gerresheimer AG Common Stock?

Gerresheimer AG XSWX:GXI +0.24% 73 Common Stock is CHF32 Mil as of Aug. 2025. GuruFocus rates XSWX:GXI with a GF Score™ of 73/100 and a GF Value™ of CHF87.96 (Possible Value Trap). The stock has 3 warning signs investors should review.

Gerresheimer AG's quarterly common stock declined from Feb. 2025 (CHF33 Mil) to May. 2025 (CHF32 Mil) but then increased from May. 2025 (CHF32 Mil) to Aug. 2025 (CHF32 Mil).

Gerresheimer AG's annual common stock increased from Nov. 2022 (CHF31 Mil) to Nov. 2023 (CHF33 Mil) but then declined from Nov. 2023 (CHF33 Mil) to Nov. 2024 (CHF32 Mil).

Gerresheimer AG Common Stock Historical Data

* Premium members only.

The historical data trend for Gerresheimer AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gerresheimer AG Common Stock Chart

Gerresheimer AG Annual Data
Trend Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.81 33.02 30.92 33.28 32.30

Gerresheimer AG Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.67 32.30 32.50 32.32 32.40
XSWX:GXI
73GF Score
Gerresheimer AG XSWX:GXI
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gerresheimer AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of CHF32 Mil mean?
Gerresheimer AG (XSWX:GXI) has a Common Stock of CHF32 Mil as of Aug. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gerresheimer AG and its competitors.
Is Gerresheimer AG's Common Stock too high?
Gerresheimer AG's current Common Stock is CHF32 Mil. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Common Stock compare to ISRG and BDX?
Gerresheimer AG's Common Stock of CHF32 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gerresheimer AG and its competitors. Gerresheimer AG's current Common Stock is CHF32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.96, compared to a current price of CHF25.02 — trading 71.6% below its estimated fair value. The current Common Stock is CHF32 Mil. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current Common Stock is CHF32 Mil as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?

Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued. The current stock price of CHF25.02 is trading 71.6% below its estimated GF Value™ of CHF87.96. GuruFocus considers Gerresheimer AG to be Possible Value Trap.

Key valuation signals for XSWX:GXI:

  • Common Stock: CHF32 Mil
  • GF Value™: CHF87.96 vs. price of CHF25.02 (71.6% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gerresheimer AG Business Description

Address Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score

Get the complete analysis for XSWX:GXI

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF25.02
Price
CHF87.96
GF Value